Search Results - "BÜNEKER, Chirlei"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Constitutively Activated Nuclear Factor-κB, but not Induced NF-κB, Leads to TRAIL Resistance by Up-Regulation of X-Linked Inhibitor of Apoptosis Protein in Human Cancer Cells by Braeuer, Susanne J., Büneker, Chirlei, Mohr, Andrea, Zwacka, Ralf Michael

    Published in Molecular cancer research (01-10-2006)
    “…The tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) is a potent inducer of apoptosis in most, but not all, cancer cells. The molecular factors…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis by MOHR, Andrea, ZWACKA, Ralf Michael, JARMY, Gergely, BÜNEKER, Chirlei, SCHREZENMEIER, Hubert, DÖHNER, Konstanze, BELTINGER, Christian, WIESNETH, Markus, DEBATIN, Klaus-Michael, STAHNKE, Karsten

    Published in Oncogene (31-03-2005)
    “…Regulation of sensitivity or resistance for apoptosis by death receptor ligand systems is a key control mechanism in the hematopoietic system. Dysfunctional or…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Role of CX3CR1 receptor in monocyte/macrophage driven neovascularization by Kumar, Arun H S, Martin, Kenneth, Turner, Elizebeth C, Buneker, Chirlei K, Dorgham, Karim, Deterre, Philippe, Caplice, Noel M

    Published in PloS one (21-02-2013)
    “…Monocyte/macrophages are implicated in initiation of angiogenesis, tissue/organ perfusion and atherosclerosis biology. We recently showed that chemokine…”
    Get full text
    Journal Article
  6. 6
  7. 7

    IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells by Büneker, Chirlei Klein, Yu, Rui, Deedigan, Laura, Mohr, Andrea, Zwacka, Ralf Michael

    Published in Cancer letters (28-03-2012)
    “…Abstract The tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a specific and potent inducer of apoptosis in cancer cells, but the resistance…”
    Get full text
    Journal Article
  8. 8

    The TRAIL-receptor-1 : TRAIL-receptor-3 and -4 ratio is a predictor for TRAIL sensitivity of cancer cells by BÜNEKER, Chirlei, MOHR, Andrea, ZWACKA, Ralf Michael

    Published in Oncology reports (01-05-2009)
    “…The tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potent inducer of apoptosis in many cancer cells. However, a significant proportion…”
    Get full text
    Journal Article
  9. 9

    IFN-[gamma] combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells by Büneker, Chirlei Klein, Yu, Rui, Deedigan, Laura, Mohr, Andrea, Zwacka, Ralf Michael

    Published in Cancer letters (28-03-2012)
    “…The tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a specific and potent inducer of apoptosis in cancer cells, but the resistance of many…”
    Get full text
    Journal Article
  10. 10

    Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells by Braeuer, Susanne J, Büneker, Chirlei, Mohr, Andrea, Zwacka, Ralf Michael

    Published in Molecular cancer research (01-10-2006)
    “…The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potent inducer of apoptosis in most, but not all, cancer cells. The molecular factors…”
    Get full text
    Journal Article
  11. 11

    Role of CX.sub.3CR1 Receptor in Monocyte/Macrophage Driven Neovascularization by Kumar, Arun H. S, Martin, Kenneth, Turner, Elizebeth C, Buneker, Chirlei K, Dorgham, Karim, Deterre, Philippe, Caplice, Noel M

    Published in PloS one (21-02-2013)
    “…Monocyte/Macrophages are implicated in initiation of angiogenesis, tissue/organ perfusion and atherosclerosis biology. We recently showed that chemokine…”
    Get full text
    Journal Article